Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2013. The report serves as a notification of transactions involving Directors and Persons Discharging Managerial Responsibility in the company's Ordinary Shares, filed pursuant to Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of share transactions rather than a financial performance report.
Material Changes
The filing details specific share acquisitions by company executives on July 9, 2013, executed through the Company's ShareReward Plan at a price of 1737.56 pence per Ordinary Share. The transactions involved both personal contributions and matching company contributions.
- Sir Andrew Witty: Acquired 7 shares (personal) and 7 shares (company match).
- Mr S Dingemans: Acquired 7 shares (personal) and 7 shares (company match).
- Mr S M Bicknell: Acquired 7 shares (personal) and 7 shares (company match).
- Mr R G Connor: Acquired 7 shares (personal) and 7 shares (company match).
- Mr D S Redfern: Acquired 7 shares (personal) and 7 shares (company match).
- Ms C Thomas: Acquired 7 shares (personal) and 7 shares (company match).
- Mr P C Thomson: Acquired 6 shares (personal) and 6 shares (company match).
- Dr P J T Vallance: Acquired 7 shares (personal) and 7 shares (company match).
- Ms E Walmsley: Acquired 7 shares (personal) and 7 shares (company match).
- Mrs V A Whyte: Acquired 7 shares (personal) and 7 shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a compliance notification under Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Checklist
- Verify the share price of 1737.56 pence against market data for July 9, 2013.
- Confirm the total number of shares acquired by each executive listed in the ShareReward Plan.
- Review the company's broader ShareReward Plan terms to understand the matching contribution structure.
- Check subsequent filings for any changes in executive ownership following these transactions.